Geth 1.8 – Iceberg¹

After waaay too much time under development, we’re proud to finally announce version 1.8.0 of the Go Ethereum client: Iceberg! The release fixes a lot of pain points felt by the community and ships a few notable new features, tallying up to ~170 modifi…

$1,700? Even Bitcoin’s Bear Case Is Bullish

Despite the recent plunge in bitcoin’s price from nearly $20,000 to less than $10,000, we remain convinced that bitcoin is the first of its kind in a new…

Farewell and Welcome

It is with sadness that we announce that Ming Chan, who has served as Executive Director at the Ethereum Foundation for nearly three years, is leaving the Foundation. Since her arrival in 2015, she has played a critical role in the development and succ…

To Infinity and Beyond!

Dear Ethereum community (and wonderful Etherheads!), Today, January 31, 2018, is my last day as Executive Director of the Ethereum Foundation. I’m pleased to have been able to guide the Foundation as ED with my fellow directors, team leads, and outst…

Q4 Roundup

Ethereum has grown very rapidly in the last few months. Transaction volume on the blockchain has more than doubled, surpassing 10 transactions per second for days at a time. The number of new accounts created per day passed 100,000

Devcon3 videos available now!

To accommodate the biggest post-devcon request, we’re happy to announce that Devcon3 videos are now available for viewing! As promised, we recorded sessions from both the main hall and breakout hall on all four days of Devcon3. Given we had two halls …

Devcon3!!!

A note from the ED: A big thanks to our attending dev community, presenters, internal team, sponsors, enthusiasts, volunteers, event team, students and other stakeholders for coming together for another phenomenal Devcon3! First of all, yes, video of…

The Case for an EV Semi Truck

ARK’s research illustrates that an EV Semi owner should enjoy roughly $500,000 in savings over the 15-year lifespan of the vehicle.

Gene Therapy Invites Competition

If its the cure to cancer that Kymriah and Yescarta are suggesting, then the capacity for CAR-T gene therapies will be in short supply for years.